The additional presentation is approved for the treatment of pediatric patients aged 6 to 17 years with plaque psoriasis or ...

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

The Johnson & Johnson JNJ stock has risen 4.4% in six months, adding more than $15 billion to its market value. J&J faces ...

JACK MAYE didn’t want to tell anybody. In his freshman year, when he took off his Bedford High School football helmet and flakes fell out, Maye’s teammates would tell him that he had some bad dandruff ...

JACK MAYE didn’t want to tell anybody. In his freshman year, when he took off his Bedford High School football helmet and flakes fell out, Maye’s teammates would tell him that he had some bad dandruff ...

Pfizer PFE is likely to encounter several headwinds in the next couple of years that can hurt its sales and profits, the ...

Late last week, J&J said that the new approach for Xarelto and Stelara – both drugs subject to the first round of Medicare negotiations under the Inflation Reduction Act (IRA) with prices ...

A GLP-1 in pill form from Eli Lilly shows promising results for weight loss and Type 2 diabetes treatment in a trial. FDA approval is expected in 2026.